Published in Crit Rev Oncol Hematol on January 25, 2012
Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res (2012) 1.26
Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer. World J Surg Oncol (2015) 0.80
Doing palliative care in the oncology office. J Oncol Pract (2013) 0.78
Decompressive percutaneous endoscopic gastrostomy in advanced cancer patients with small-bowel obstruction is feasible and effective: a large prospective study. Support Care Cancer (2016) 0.78
Symptom management in the older adult: 2015 update. Clin Geriatr Med (2015) 0.75
Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel. Case Rep Oncol (2016) 0.75
The use of octreotide to manage symptoms of bronchorrhea: a case report. J Pain Symptom Manage (2013) 0.75
Outcome prognostic factors in inoperable malignant bowel obstruction. Support Care Cancer (2016) 0.75
Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage (2004) 1.67
Physical exercise and quality of life in breast cancer survivors. Int J Med Sci (2008) 1.14
Palliative sedation in patients with advanced cancer followed at home: a systematic review. J Pain Symptom Manage (2011) 1.06
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (2008) 1.04
Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin (2012) 0.91
The medical oncologist's role in palliative care: AIOM's position. Tumori (2010) 0.91
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line. Anticancer Res (2004) 0.90
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer (2007) 0.90
Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage (2006) 0.87
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Curr Med Res Opin (2013) 0.87
Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses. Curr Med Res Opin (2012) 0.86
How do cancer patients receiving palliative care at home die? A descriptive study. J Pain Symptom Manage (2011) 0.86
Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine. J Pain Symptom Manage (2007) 0.86
Emergencies in patients with advanced cancer followed at home. J Pain Symptom Manage (2012) 0.84
Triplet chemotherapy in patients with metastatic colorectal cancer: toward the best way to safely administer a highly active regimen in clinical practice. Clin Colorectal Cancer (2012) 0.84
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis. J Pain Symptom Manage (2012) 0.84
Breakthrough pain in oncology: a longitudinal study. J Pain Symptom Manage (2010) 0.83
Prognostic factors of survival in patients with advanced cancer admitted to home care. J Pain Symptom Manage (2012) 0.83
Spinal analgesia for advanced cancer patients: an update. Crit Rev Oncol Hematol (2011) 0.83
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain (2009) 0.82
Is there still a role for the uniscale assessment of quality of life? Tumori (2007) 0.82
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain. Curr Med Res Opin (2014) 0.81
Efficacy of pregabalin in the management of cetuximab-related itch. J Pain Symptom Manage (2006) 0.80
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. Curr Med Res Opin (2013) 0.80
Palliative sedation in advanced cancer patients followed at home: a retrospective analysis. J Pain Symptom Manage (2012) 0.80
Knowledge and attitudes of Italian medical oncology residents toward the approach and treatment of pain. J Pain Symptom Manage (2003) 0.79
Does pain intensity predict a poor opioid response in cancer patients? Eur J Cancer (2011) 0.79
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients. Clin J Pain (2013) 0.78
Pain characteristics and analgesic treatment in an aged adult population: a 4-week retrospective analysis of advanced cancer patients followed at home. Drugs Aging (2015) 0.78
Pain intensity as prognostic factor in cancer pain management. Pain Pract (2014) 0.78
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting. Support Care Cancer (2013) 0.77
Topical morphine in the treatment of painful ulcers. J Pain Symptom Manage (2005) 0.75
Palliative care in advanced cancer patients: how and when? And where? Oncologist (2012) 0.75
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? J Pain Symptom Manage (2007) 0.75
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit. J Pain Symptom Manage (2011) 0.75
Orphan symptoms in advanced cancer patients followed at home. Support Care Cancer (2013) 0.75
Morphine in the treatment of incident pain triggered by vinorelbine infusion. J Pain Symptom Manage (2008) 0.75
Inappropriate doses of chemotherapy in Italian breast cancer patients enrolled in clinical trials. Tumori (2008) 0.75
Is there a role for neurologist in an oncological home care team? Neurol Sci (2012) 0.75
Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting. J Opioid Manag (2007) 0.75
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer. Breast J (2007) 0.75